SCHEMBL7982882

SCHEMBL7982882

NCc1ccc2c(c1)CN(CCCc1ccccc1)C2

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 11/20 0.53
LTA4H P09960 1/20 0.48
HRH3 Q9Y5N1 1/20 0.46
POLB P06746 1/20 0.45
GRIN2B Q13224 1/20 0.44
NAMPT P43490 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984485 0.85 NAMPT (0.60) SIGMAR1LTA4HHRH3POLBGRIN2B
SCHEMBL7041746 0.81 SIGMAR1 (0.54) SIGMAR1POLB
SCHEMBL10382817 0.78 SIGMAR1 (0.58) SIGMAR1LTA4HPOLBGRIN2B
SCHEMBL7981844 0.78 ADRA1D (0.55)
Lithium Ion SCHEMBL8530253 0.78 SIGMAR1 (0.50) SIGMAR1
SCHEMBL7982875 0.77 SIGMAR1 (0.49) SIGMAR1LTA4HHRH3POLBGRIN2B
SCHEMBL7985762 0.77 OPRM1 (0.43) SIGMAR1LTA4HHRH3NAMPT
SCHEMBL10383389 0.75 SIGMAR1 (0.63) SIGMAR1
SCHEMBL27746973 0.75 SIGMAR1 (0.74) SIGMAR1
SCHEMBL16978068 0.74 DRD2 (0.56) SIGMAR1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed